Literature DB >> 17237116

Further evidence of the role of frizzled-related protein gene polymorphisms in osteoarthritis.

J Rodriguez-Lopez1, M Pombo-Suarez, M Liz, J J Gomez-Reino, A Gonzalez.   

Abstract

OBJECTIVE: To replicate the association of frizzled-related protein (FRZB) non-synonymous polymorphisms with osteoarthritis (OA) susceptibility.
METHODS: Three groups of Spanish patients with OA were included: with total joint replacement due to primary OA in the hip (n = 310), or the knee (n = 277), or with hand OA (n = 242). Controls were more than 55 years old and did not show OA (n = 294). SNPs rs288326 (R200W) and rs7775 (R324G) were genotyped.
RESULTS: There were no significant differences in allele frequencies between controls and each of the three groups of OA patients. However, allele G of the R324G SNP showed a trend to be more frequent in patients with a clinical OA syndrome at multiple joints (p = 0.07), specifically in women of the total hip replacement group (8.3% in patients without other affected joints, 13.1% with one, 15.9% with two and 24.1% with more than two additional joints, p for trend = 0.008).
CONCLUSIONS: No direct replication of previous OA association findings was obtained but the results suggest that the R324G SNP of the FRZB gene may have an effect in OA development in multiple joints, with a specific severe involvement of the hip in women. This phenotype could reconcile previous studies that showed association either with generalised OA or with hip OA in women.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17237116      PMCID: PMC1954696          DOI: 10.1136/ard.2006.065938

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  18 in total

1.  Replication of the association of the aspartic acid repeat polymorphism in the asporin gene with knee-osteoarthritis susceptibility in Han Chinese.

Authors:  Qing Jiang; Dongquan Shi; Long Yi; Shiro Ikegawa; Yong Wang; Takahiro Nakamura; Di Qiao; Cheng Liu; Jin Dai
Journal:  J Hum Genet       Date:  2006-09-21       Impact factor: 3.172

2.  The Wnt antagonist Frzb-1 regulates chondrocyte maturation and long bone development during limb skeletogenesis.

Authors:  Motomi Enomoto-Iwamoto; Jirouta Kitagaki; Eiki Koyama; Yoshihiro Tamamura; Changshan Wu; Naoko Kanatani; Tatsuya Koike; Hiroshi Okada; Toshihisa Komori; Toshiyuki Yoneda; Vicki Church; Philippa H Francis-West; Kojiro Kurisu; Tsutomu Nohno; Maurizio Pacifici; Masahiro Iwamoto
Journal:  Dev Biol       Date:  2002-11-01       Impact factor: 3.582

3.  Statistical false positive or true disease pathway?

Authors:  John A Todd
Journal:  Nat Genet       Date:  2006-07       Impact factor: 38.330

4.  Allelic expression analysis suggests that cis-acting polymorphism of FRZB expression does not contribute to osteoarthritis susceptibility.

Authors:  S Snelling; A Ferreira; J Loughlin
Journal:  Osteoarthritis Cartilage       Date:  2006-08-02       Impact factor: 6.576

5.  Clusters of biochemical markers are associated with radiographic subtypes of osteoarthritis (OA) in subject with familial OA at multiple sites. The GARP study.

Authors:  I Meulenbelt; M Kloppenburg; H M Kroon; J J Houwing-Duistermaat; P Garnero; M-P Hellio-Le Graverand; J DeGroot; P E Slagboom
Journal:  Osteoarthritis Cartilage       Date:  2006-10-17       Impact factor: 6.576

6.  Frizzled-related protein variants are risk factors for hip osteoarthritis.

Authors:  N E Lane; K Lian; M C Nevitt; J M Zmuda; L Lui; J Li; J Wang; M Fontecha; N Umblas; M Rosenbach; P de Leon; M Corr
Journal:  Arthritis Rheum       Date:  2006-04

7.  The Wnt antagonist secreted frizzled-related protein-1 is a negative regulator of trabecular bone formation in adult mice.

Authors:  Peter V N Bodine; Weiguang Zhao; Yogendra P Kharode; Frederick J Bex; Andre-Jean Lambert; Mary Beth Goad; Tripti Gaur; Gary S Stein; Jane B Lian; Barry S Komm
Journal:  Mol Endocrinol       Date:  2004-02-19

Review 8.  Burden of major musculoskeletal conditions.

Authors:  Anthony D Woolf; Bruce Pfleger
Journal:  Bull World Health Organ       Date:  2003-11-14       Impact factor: 9.408

9.  Functional variants within the secreted frizzled-related protein 3 gene are associated with hip osteoarthritis in females.

Authors:  John Loughlin; Barbara Dowling; Kay Chapman; Lucy Marcelline; Zehra Mustafa; Lorraine Southam; Athena Ferreira; Cathleen Ciesielski; Dennis A Carson; Maripat Corr
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-21       Impact factor: 11.205

10.  Lack of association of a variable number of aspartic acid residues in the asporin gene with osteoarthritis susceptibility: case-control studies in Spanish Caucasians.

Authors:  Julio Rodriguez-Lopez; Manuel Pombo-Suarez; Myriam Liz; Juan J Gomez-Reino; Antonio Gonzalez
Journal:  Arthritis Res Ther       Date:  2006-03-10       Impact factor: 5.156

View more
  16 in total

Review 1.  Role of bone architecture and anatomy in osteoarthritis.

Authors:  Julie C Baker-LePain; Nancy E Lane
Journal:  Bone       Date:  2012-01-24       Impact factor: 4.398

Review 2.  Relationship between joint shape and the development of osteoarthritis.

Authors:  Julie C Baker-LePain; Nancy E Lane
Journal:  Curr Opin Rheumatol       Date:  2010-09       Impact factor: 5.006

Review 3.  A Comprehensive Overview of Skeletal Phenotypes Associated with Alterations in Wnt/β-catenin Signaling in Humans and Mice.

Authors:  Kevin A Maupin; Casey J Droscha; Bart O Williams
Journal:  Bone Res       Date:  2013-03-29       Impact factor: 13.567

4.  Variant alleles of the Wnt antagonist FRZB are determinants of hip shape and modify the relationship between hip shape and osteoarthritis.

Authors:  Julie C Baker-Lepain; John A Lynch; Neeta Parimi; Charles E McCulloch; Michael C Nevitt; Maripat Corr; Nancy E Lane
Journal:  Arthritis Rheum       Date:  2012-05

5.  The retinoic acid binding protein CRABP2 is increased in murine models of degenerative joint disease.

Authors:  Ian D Welch; Matthew F Cowan; Frank Beier; Tully M Underhill
Journal:  Arthritis Res Ther       Date:  2009-01-28       Impact factor: 5.156

6.  Wnt/beta-catenin and retinoic acid receptor signaling pathways interact to regulate chondrocyte function and matrix turnover.

Authors:  Rika Yasuhara; Takahito Yuasa; Julie A Williams; Stephen W Byers; Salim Shah; Maurizio Pacifici; Masahiro Iwamoto; Motomi Enomoto-Iwamoto
Journal:  J Biol Chem       Date:  2009-10-26       Impact factor: 5.157

7.  Large-scale analysis of association between GDF5 and FRZB variants and osteoarthritis of the hip, knee, and hand.

Authors:  Evangelos Evangelou; Kay Chapman; Ingrid Meulenbelt; Fotini B Karassa; John Loughlin; Andrew Carr; Michael Doherty; Sally Doherty; Juan J Gómez-Reino; Antonio Gonzalez; Bjarni V Halldorsson; Valdimar B Hauksson; Albert Hofman; Deborah J Hart; Shiro Ikegawa; Thorvaldur Ingvarsson; Qing Jiang; Ingileif Jonsdottir; Helgi Jonsson; Hanneke J M Kerkhof; Margreet Kloppenburg; Nancy E Lane; Jia Li; Rik J Lories; Joyce B J van Meurs; Annu Näkki; Michael C Nevitt; Julio Rodriguez-Lopez; Dongquan Shi; P Eline Slagboom; Kari Stefansson; Aspasia Tsezou; Gillian A Wallis; Christopher M Watson; Tim D Spector; Andre G Uitterlinden; Ana M Valdes; John P A Ioannidis
Journal:  Arthritis Rheum       Date:  2009-06

8.  The Expressions of Dickkopf-Related Protein 1 and Frizzled-Related Protein Are Negatively Correlated to Local Inflammation and Osteoarthritis Severity.

Authors:  Xiaobin Huang; Leilei Zhong; Eefje van Helvoort; Floris Lafeber; Simon Mastbergen; Jan Hendriks; Janine N Post; Marcel Karperien
Journal:  Cartilage       Date:  2019-04-04       Impact factor: 4.634

Review 9.  Genetic polymorphism in extracellular regulators of Wnt signaling pathway.

Authors:  Garima Sharma; Ashish Ranjan Sharma; Eun-Min Seo; Ju-Suk Nam
Journal:  Biomed Res Int       Date:  2015-04-05       Impact factor: 3.411

10.  Genetics in osteoarthritis.

Authors:  Mercedes Fernández-Moreno; Ignacio Rego; Vanessa Carreira-Garcia; Francisco J Blanco
Journal:  Curr Genomics       Date:  2008-12       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.